OP0147 KAWAKINRA: A PHASE IIA MULTICENTER TRIAL TO ASSESS THE EFFICACY, AND SAFETY OF ANAKINRA IN PATIENTS WITH INTRAVENOUS IMMUNOGLOBULIN-RESISTANT KAWASAKI DISEASE

Isabelle Koné-Paut; Stephanie Tellier; Virginie Lambert; Corinne Guitton; Alexandre Belot; Perrine Dusser; Linda Rossi-Semerano; Isabelle Marie; Gregory Allain; Helene Agostini; Celine Piedvache

doi:10.1136/annrheumdis-2019-eular.5633

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Oral Presentations

THURSDAY, 13 JUNE 2019

Vasculitis

OP0147 KAWAKINRA: A PHASE IIA MULTICENTER TRIAL TO ASSESS THE EFFICACY, AND SAFETY OF ANAKINRA IN PATIENTS WITH INTRAVENOUS IMMUNOGLOBULIN-RESISTANT KAWASAKI DISEASE

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Koné-Paut I, Tellier S, Lambert V, et al

OP0147 KAWAKINRA: A PHASE IIA MULTICENTER TRIAL TO ASSESS THE EFFICACY, AND SAFETY OF ANAKINRA IN PATIENTS WITH INTRAVENOUS IMMUNOGLOBULIN-RESISTANT KAWASAKI DISEASE

Annals of the Rheumatic Diseases 2019;78:149.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password